You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery

Article metrics

Article menu

Download PDFPDF

XML
Case report
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery

 

Online download statistics by month:

Online download statistics by month: August 2020 to September 2025

AbstractFullPdf
Aug 2020155155102
Sep 202015515578
Oct 2020505026
Nov 2020818237
Dec 2020424218
Jan 2021767629
Feb 2021363614
Mar 2021878738
Apr 2021484813
May 2021393913
Jun 2021383851
Jul 2021404048
Aug 2021181887
Sep 2021606064
Oct 2021878760
Nov 2021444349
Dec 2021272721
Jan 2022657037
Feb 2022454513
Mar 2022616332
Apr 2022768340
May 2022585832
Jun 2022545524
Jul 2022353927
Aug 2022475423
Sep 2022667056
Oct 2022606344
Nov 2022687234
Dec 2022373713
Jan 2023495117
Feb 2023848530
Mar 2023838526
Apr 2023404231
May 2023444430
Jun 2023424222
Jul 2023414325
Aug 2023444520
Sep 2023333317
Oct 2023525625
Nov 2023525427
Dec 2023696935
Jan 2024585929
Feb 2024545524
Mar 2024535366
Apr 2024495147
May 2024697128
Jun 2024494827
Jul 2024707224
Aug 2024393864
Sep 2024444421
Oct 2024505027
Nov 2024495029
Dec 2024687434
Jan 2025525222
Feb 2025606030
Mar 2025595931
Apr 2025818134
May 2025919357
Jun 2025373722
Jul 2025110
Sep 2025110
Total342234902044